Information  X 
Enter a valid email address

Tristel PLC (TSTL)

  Print          Annual reports

Wednesday 22 September, 2021

Tristel PLC

Notice of Results

RNS Number : 5076M
Tristel PLC
22 September 2021

Tristel plc

("Tristel" or the "Company")


Notice of Results

Investor briefing


Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that its preliminary results for the year ended 30 June 2021 will be announced on Monday 18 October 2021.


Investor presentation

Paul Swinney, CEO, and Liz Dixon, CFO, will present the Company's results at an in-person investor presentation on Monday 18 October 2021 at No.1 Cornhill, London, EC3V 3ND from 4.15pm for a 4.30pm start and will be followed by refreshments.


For those that are unable to attend, a live webcast of the investor briefing will be broadcast.


If you would like to register to attend in-person, or require the link for the live webcast, please contact Walbrook PR on 020 7933 8787 or email [email protected] , ensuring you detail in your email if you will attend in-person or online.


The results presentation will be made available on the Company's website on the day of results -  




For further information please contact: 


Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer


Liz Dixon,  Chief Financial Officer


Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303



Tel: 020 7220 0500

Geoff Nash / Charlie Beeson , Corporate Finance


Alice Lane, ECM










This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t